6-89411938-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021244.5(RRAGD):c.56A>T(p.Glu19Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000454 in 1,540,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_021244.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151862Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000716 AC: 1AN: 139586Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 75226
GnomAD4 exome AF: 0.00000360 AC: 5AN: 1388924Hom.: 0 Cov.: 32 AF XY: 0.00000146 AC XY: 1AN XY: 685700
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151862Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74138
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 11, 2024 | The c.56A>T (p.E19V) alteration is located in exon 1 (coding exon 1) of the RRAGD gene. This alteration results from a A to T substitution at nucleotide position 56, causing the glutamic acid (E) at amino acid position 19 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at